UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~June~~September 30, 2022

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 001-40723

ABRI SPAC 2, INC.

(Exact name of registrant as specified in its charter)

Delaware

87-1757836

(State or other jurisdiction of

incorporation or organization)

(IRS Employer

Identification No.)

40 Main Street, #1009
Newark, DE 19711

(Address of principal executive offices and zip code)

(424) 732-1021

(Registrant’s telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Units, each consisting of one share of Common Stock, one Redeemable Warrant, and one Right	ASPPU	The Nasdaq Stock Market LLC
Common Stock, par value $0.0001 per share	ASPP	The Nasdaq Stock Market LLC
Warrants, each exercisable for one share of Common Stock for $11.50 per share	ASPPW	The Nasdaq Stock Market LLC

Rights, each right to receive one-tenth of one share of common stock upon the consummation of an initial business combination	ASPPR	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

Large accelerated filer ☐	Accelerated filer ☐
Non-accelerated filer ☒	Smaller reporting company ☒
	Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

As of ~~October~~November 1114, 2022, there were 1,725,000 shares of common stock, par value $0.0001 per share, issued and outstanding.

ABRI SPAC 2, INC.

TABLE OF CONTENTS

		Page
PART 1 – FINANCIAL INFORMATION
Item 1.	FINANCIAL STATEMENTS (UNAUDITED)	1
	Condensed Balance Sheets as of June 30, 2022 and December 31, 2021 (Unaudited)	1
	Condensed Balance Sheets as of September 30, 2022 (Unaudited) and December 31, 2021 (Audited)	1
	Condensed Statements of Operations for the three and six months ended June 30, 2022 (Unaudited)	2
	Condensed Statements of Operations for the three and nine months ended September 30, 2022, and the Period From July 19, 2021 (Inception) Through September 30, 2021 (Unaudited)	2
	Condensed Statement of Changes in Stockholders’ Deficit for the three and six months ended June 30, 2022 (Unaudited)	3
	Condensed Statement of Changes in Stockholders’ Deficit for the three and nine months ended September 30, 2022, and the Period From July 19, 2021 (Inception) Through September 30, 2021 (Unaudited)	3
	Condensed Statement of Cash Flows for the period from January 1, 2022 through June 30, 2022 (unaudited)	4
	Condensed Statement of Cash Flows for the period from January 1, 2022 through September 30, 2022, and the Period From July 19, 2021 (Inception) Through September 30, 2021 (Unaudited)	4
	Notes to Unaudited Condensed Financial Statements	5
Item 2.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	11
Item 3.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	14
Item 4.	CONTROLS AND PROCEDURES	14
PART II – OTHER INFORMATION
Item 1.	LEGAL PROCEEDINGS	15
Item 1A.	RISK FACTORS	15
Item 2.	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS	15
Item 3.	DEFAULTS UPON SENIOR SECURITIES	15
Item 4.	MINE SAFETY DISCLOSURES	15
Item 5.	OTHER INFORMATION	15
Item 6.	EXHIBITS	16
SIGNATURES		17

PART I – FINANCIAL INFORMATION

ITEM 1. Unaudited Financial Statements

ABRI SPAC 2, INC. CONDENSED BALANCE SHEETS ~~(Unaudited)~~

	June 30, 2022			December 31, 2021
	September 30, 2022			December 31, 2021
	(Unaudited)			(Audited)
CURRENT ASSETS
Cash	$	~~216~~229,380		$	234,069
Prepaid expenses		43,~~750~~125			5,000
Total current assets		4232,~~966~~505			239,069
Deferred offering costs associated with proposed public offering		~~579~~633,~~061~~000			89,606
Total assets	$	~~584~~865,~~027~~505		$	328,675
LIABILITIES AND STOCKHOLDER’S (DEFICIT) EQUITY
LIABILITIES AND STOCKHOLDER’S EQUITY
Current liabilities:
Accounts payable and accrued expenses	$	~~348~~335,~~321~~768		$	4,956
Note payable – related party		300,000			300,000
Due to Sponsor		29,634			-
Convertible promissory note – related party		122,439			-
Total current liabilities		~~677~~758,~~955~~207			304,956
Total liabilities		~~677~~758,~~955~~207			304,956
Commitments and Contingencies
Stockholder’s (deficit) equity:
Stockholder’s equity:
Preferred stock, par value $0.0001, 1,000,000 shares authorized, none issued and outstanding		-			-
Common stock, par value $0.0001, 100,000,000 shares authorized; 1,725,000 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively(1)		173			173
Common stock, par value $0.0001, 100,000,000 shares authorized; 1,725,000 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively(1)		173			173
Additional paid-in capital		24,827			24,827
Accumulated deficit		(118,928	)		(1,281	)
Accumulated surplus (deficit)		82,298			(1,281	)
Total stockholder’s (deficit) equity		(93,928	)		23,719
Total stockholder’s equity		107,298			23,719
Total liabilities and stockholder’s (deficit) equity	$	584,027		$	328,675
Total liabilities and stockholder’s equity	$	865,505		$	328,675

(1) Includes up to 225,000 shares of subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 4).

The accompanying notes are an integral part of these unaudited condensed financial statements

ABRI SPAC 2, INC.

CONDENSED STATEMENT OF OPERATIONS

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2022

(Unaudited)

	Three Months Ended			~~Six~~Nine Months Ended			For the period July 19, 2021 (Inception) Through
	June 30, 2022			June 30, 2022
	September 30, 2022			September 30, 2022			September 30, 2021
Operating expenses:
General and administrative	$	7376,~~271~~335		$	~~117~~193,~~647~~982		$	882
Loss from operations		(7376,~~271~~335	)		(~~117~~193,~~647~~982	)		(882	)
Loss before income taxes		(73,271	)		(117,647	)
Other income:
Benefit from (provision for) income taxes		-			-
Inception Gain (Fair Value of Convertible Promissory Note)		277,561			277,561
Net loss	$	(73,271	)	$	(117,647	)
Income (Loss) before income taxes		201,226			83,579			(882	)
Weighted-average common shares outstanding, basic and diluted(1)		1,500,000			1,500,000
Benefit from (provision for) income taxes		-			-			-
Basic and diluted net loss per common share	$	(0.05	)	$	(0.08	)
Net income (loss)	$	201,226		$	83,579		$	(882	)
Weighted-average common shares outstanding, basic and diluted(1)		1,500,000			1,500,000			1,500,000
Basic and diluted net income per common share	$	0.13		$	0.06		$	(0.00	)

(1)

Excludes up to 225,000 shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 4).

The accompanying notes are an integral part of these unaudited condensed financial statements

ABRI SPAC 2, INC.

CONDENSED STATEMENT OF CHANGES IN STOCKHOLDER’S EQUITY (DEFICIT) ~~EQUITY~~

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2022

(Unaudited)

	Common Stock				Additional Paid-in		Accumulated Surplus			Total Stockholder’s ~~(Deficit)~~Equity
	Shares(1)		Amount		Capital		(Deficit)			~~Equity~~(Deficit)
Balance, March 31, 2022		1,725,000	$	173	$	24,827	$	(45,657	)	$	(20,657	)
Balance, June 30, 2022		1,725,000	$	173	$	24,827	$	(118,928	)	$	(93,928	)
Net loss		—		—		—		(73,271	)		(73,271	)
Net income		-		-		-		201,226			201,226
Balance at June 30, 2022		1,725,000	$	173	$	24,827	$	(118,928	)	$	(93,928	)
Balance at September 30, 2022		1,725,000	$	173	$	24,827	$	82,298		$	107,298

	Common Stock				Additional Paid-in		Accumulated Surplus			Total Stockholder’s ~~(Deficit)~~
	Shares(1)		Amount		Capital		(Deficit)			Equity
Balance, January 1, 2022		1,725,000	$	173	$	24,827	$	(1,281	)	$	23,719
Net loss		—		—		—		(117,647	)		(117,647	)
Net income		-		-		-		83,579			83,579
Balance at June 30, 2022		1,725,000	$	173	$	24,827	$	(118,928	)	$	(93,928	)
Balance at September 30, 2022		1,725,000	$	173	$	24,827	$	82,298		$	107,298

	Common Stock				Additional Paid-in		Accumulated			Total Stockholder’s
	Shares⁽¹⁾		Amount		Capital		Deficit			Equity
Balance, July 19, 2021 (inception)		-	$	-	$	-	$	-		$	-
Issuance of common stock to sponsor		1,725,000		287		24,713					25,000
Net loss		-		-		-		(882	)		(882	)
Balance at September 30, 2021		1,725,000	$	287	$	24,713	$	(882	)	$	24,118

(1)

Includes up to 225,000 shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 4).

The accompanying notes are an integral part of these unaudited condensed financial statements

ABRI SPAC 2, INC.

CONDENSED STATEMENT OF CASH FLOWS

FOR THE SIX MONTHS ENDED JUNE 30, 2022

(Unaudited)

	June 30,
				For the period July 19, 2021 (Inception) Through
	2022
	September 30, 2022			September 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(117,647	)
Net income (loss)	$	83,579			(882	)
Adjustments to reconcile net loss to net cash used in operating activities:
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Changes in operating assets and liabilities:
Inception Gain (Fair Value of Convertible Promissory Note)		(277,561	)		-
Prepaid expenses		250
Changes in operating assets and liabilities:
Accounts payable and accrued expenses		87,334
Prepaid expenses		1,875			-
Net cash used in operating activities		(30,063	)
Accounts payable and accrued expenses		150,087			-
CASH FLOWS FROM FINANCING ACTIVITIES:
Due to Sponsor					882
Payment of deferred offering costs		(203,790	)
Net cash used in operating activities		(42,020	)		-
Net cash used in financing activities		(203,790	)
CASH FLOWS FROM FINANCING ACTIVITIES:
NET CHANGE IN CASH		(233,853	)
Payment of deferred offering costs		(203,790	)		-
Cash – Beginning of period		234,069
Proceeds from Convertible promissory note – related party		241,121			-
Cash – End of period	$	216
Net cash provided by financing activities		37,331			-
SUPPLEMENTAL CASH FLOW INFORMATION:
NET CHANGE IN CASH		(4,689	)		-
Non-cash financing activities:
Cash – Beginning of period		234,069			-
Deferred costs recorded in accounts payable and accrued expenses	$	260,588
Cash – End of period	$	229,380			-
Deferred costs recorded in Due to Sponsor	$	29,634
SUPPLEMENTAL CASH FLOW INFORMATION:
Non-cash financing activities:
Deferred costs recorded in accounts payable and accrued expenses	$	235,567		$	113
Deferred costs paid by Sponsor recorded in Note payable – related party				$	74,118
Deferred costs paid by Sponsor recorded in Convertible promissory note – related party	$	64,904			-
Other costs paid by Sponsor recorded in Convertible promissory note – related party	$	93,975

The accompanying notes are an integral part of these unaudited condensed financial statements

ABRI SPAC 2, INC.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

FOR THE ~~SIX~~NINE MONTHS ENDED ~~JUNE~~SEPTEMBER 30, 2022

(Unaudited)

NOTE 1 — NATURE OF THE ORGANIZATION AND BUSINESS

Description of Business

Abri SPAC 2, Inc. (“Abri 2” or the “Company”) was incorporated in the State of Delaware on July 19, 2021. The Company’s business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company has selected December 31 as its fiscal year end. Throughout this report, the terms “our,” “we,” “us,” and the “Company” refer to Abri SPAC 2, Inc.

As of ~~June~~September 30, 2022 and the date of this filing, the Company had not commenced core operations. All activity for the period from July 19, 2021 (inception) through ~~June~~September 30, 2022 relates to the Company’s formation and raising funds through the proposed initial public offering (“Proposed Public Offering”), which is described below. The Company will not generate any operating revenues until after the completion of a business combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Proposed Public Offering.

Our ability to commence operations is contingent upon obtaining adequate financial resources through a Proposed Public Offering.

Net proceeds from the Proposed Public Offering and the sale of the units we are selling to Abri Ventures 2, LLC (our “Sponsor”) and/or its designee in a private placement simultaneously with the closing of this Proposed Public Offering (“Private Units”) will be placed in a trust account (“Trust Account”) in the United States. Except with respect to interest earned on the funds held in the Trust Account that may be released to us to pay our income or other tax obligations, the proceeds will not be released from the Trust Account until the earlier of the completion of our business combination or our redemption of 100% of the outstanding public shares if we have not completed a business combination in the required time period. Any amounts not paid as consideration to the sellers of the target business may be used to finance operations of the target business.

The stock exchange listing rules provide that the business combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the value of the assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable) at the time of the Company signing a definitive agreement in connection with the business combination. The Company will only complete a business combination if the post-business combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target. There is no assurance that the Company will be able to successfully effect a business combination.

Our Sponsor, officers and directors have entered into a letter agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to their insider shares and any public shares they may hold in connection with the completion of our business combination. In addition, our Sponsor, officers and directors have agreed to waive their rights to liquidating distributions from the Trust Account with respect to their insider shares if we fail to complete our business combination within the prescribed time frame. However, if our Sponsor or any of our officers, directors or affiliates acquire public shares in or after this Proposed Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such public shares if we fail to complete our business combination within the prescribed time frame.

If the Company is unable to complete its business combination, the Company will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at per- share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account and not previously released to us to pay our taxes (less up to $100,000 of interest to pay dissolution expenses) divided by the number of then outstanding public shares, and (iii) liquidate and dissolve. There will be no redemption rights or liquidating distributions with respect to the warrants, which will expire worthless if the Company fails to complete its business combination.

The Company will provide its public stockholders with the opportunity to redeem all or a portion of their shares of common stock upon the completion of the business combination either (i) in connection with a stockholder meeting called to approve the business combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a proposed business combination or conduct a tender offer will be made by the Company, solely in the Company’s discretion. The public stockholders will be entitled to redeem their shares at a per- share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation of the business combination including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its franchise and income taxes, divided by the number of then outstanding public shares, subject to the limitations. The amount in the Trust Account is initially anticipated to be approximately $10.00 per public share.

Surrender and Cancellation of Founder’s Shares

On September 30, 2021, our Sponsor paid $25,000 for 2,875,000 shares of our common stock. On May 26, 2022, our initial stockholders surrendered to us, for no consideration, an aggregate of 1,150,000 founder shares, which we cancelled, resulting in an aggregate of 1,725,000 founder shares outstanding held by our Sponsor. Common stock, number of shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters, additional paid-in-capital, and per share amount for all periods have been retroactively restated to reflect the cancellation.

Going Concern and Management’s Liquidity Plans

As of ~~June~~September 30, 2022, the Company had a cash balance of $~~216~~229,380 and a working capital deficit of $~~672~~525,~~989~~702. To date, the Company’s liquidity needs up to ~~June~~September 30, 2022, had been satisfied through proceeds from anotes ~~note~~payables ~~payable~~ from related party in the principal amount of $~~300~~700,000 and from the issuance of common stock.

The accompanying unaudited financial statements have been prepared in conformity with U.S. GAAP on the basis that the Company will continue as a going concern, which assumes the realization of assets and the satisfaction of liabilities in the normal course of business. As of ~~June~~September 30, 2022, the Company had no income from continuing operations. Based on the Company’s cash balance as of ~~June~~ September 30, 2022, and projected cash needs for the next twelve months, management estimates that it will need to consummate its Proposed Public Offering and/or raise additional capital to cover operating and capital requirements. Management will need to raise the additional funds through issuing additional shares of common stock or other equity securities or obtaining debt financing. Although management has been successful to date in raising necessary funding, there can be no assurance that such Proposed Public Offering will occur or that any required future financing can be successfully completed on a timely basis, or on terms acceptable to the Company. Based on these circumstances, management has determined that these conditions raise substantial doubt about the Company’s ability to continue as a going concern.

Risks and Uncertainties

Management continues to evaluate the impact of the COVID-19 pandemic and Russia-Ukraine war on the economy and the capital markets and has concluded that, while it is reasonably possible that such events could have negative effects on the Company’s financial position, results of its operations, and/or search for a target company, the specific impacts are not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of these uncertainties.

NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited financial statements of the Company ~~has~~ have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).

Unaudited Interim Financial Statements

The accompanying unaudited financial statements are presented in conformity with U.S. GAAP and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). In the opinion of the Company, the unaudited financial statements contain all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of its financial position as of ~~June~~ September 30, 2022, and its results of operations for the three and ~~six~~nine months ended ~~June~~September 30, 2022. ~~The accompanying unaudited financial statements do not contain comparative periods for the period ended June 30, 2021 since the Company had not been incepted until July 19, 2021.~~ Certain information or footnote disclosures normally included in unaudited financial statements prepared in accordance with U.S. GAAP have been omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been omitted pursuant to the rules of the SEC. These unaudited financial statements and related notes should be read in conjunction with the Company’s audited financial statements as of and for the period from July 19, 2021 (inception) to December 31, 2021, included elsewhere herein.

Emerging Growth Company

We are an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial ~~statement~~statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of financial ~~statement~~statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements ~~statement~~ and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial ~~statement~~statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

Cash

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of ~~June~~September 30, 2022 or December 31, 2021.

Prepaid Expenses

Prepaid expenses are comprised of the costs of website development and hosting and marketing. Such costs consisted of an upfront payment of $5,000 as of December 31, 2021 and an upfront payment of $2,500 in May 2022, and are amortized over the duration of the contracts.

Deferred Offering Costs

Deferred offering costs consist of professional fees, underwriting fees, filing, regulatory and other costs incurred through the balance sheet date that are incremental and directly related to the Proposed Public Offering. Offering costs will be allocated to the separable financial instruments issued in the Proposed Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with our common stock will be charged against the carrying value of the common stock subject to possible redemption upon the completion of the Proposed Public Offering. Should the Proposed Public Offering prove to be unsuccessful, these deferred costs, as well as additional expenses to be incurred, will be charged to operations. As of ~~June~~September 30, 2022 and December 31, 2021, a total of $~~579~~633,~~061~~000 and $89,606, respectively, in offering costs were capitalized.

Convertible Promissory Note

The Company accounts for its Convertible Note under ASC 815, “Derivatives and Hedging” (“ASC 815”). Under 815-15-25, an election can be made at the inception of a financial instrument to account for the instrument under the fair value option under ASC 825. The Company has made such election for its Convertible Note. Using the fair value option, the Convertible Note is required to be recorded at its initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the Convertible Note is recognized as a gain or loss within other income on the condensed statements of operations (see Note 3).

Income Taxes

The Company follows the asset and liability method of accounting for income taxes under ASC 740. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. ~~Valuation~~ Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be ~~sustained~~ sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of ~~June~~ September 30, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by taxing authorities since inception.

The Company has evaluated its income tax positions and has determined that it does not have any uncertain tax positions. The Company will recognize interest and penalties related to any uncertain tax positions through income tax expense.

The Company has ~~incurred~~generated ~~losses~~income from inception through ~~June~~ September 30, 2022 but has no material deferred tax assets or liabilities as of December 31, 2021 and ~~June~~September 30, 2022. The Company is subject to franchise tax filing requirements in the State of Delaware.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. As of ~~June~~September 30, 2022, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

Fair Value Measurements

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

●

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

●

Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

●

Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, Fair Value Measurements and Disclosures, approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.

Net Income (Loss) Per Share

Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the reporting period, excluding common shares subject to forfeiture by the Sponsor. Weighted average shares were reduced for the effect of an aggregate of 225,000 common shares that are subject to forfeiture. Diluted earnings per share is computed similar to basic earnings per share, except the weighted average number of common shares outstanding are increased to include additional shares from the assumed exercise of share options, if dilutive. At ~~June~~September 30, 2022, there are no outstanding dilutive or potentially dilutive instruments. As a result, dilutive income (loss) per share is the same as basic income (loss) per share for the ~~period~~ periods presented.

Recent Accounting Pronouncements

Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

NOTE 3 — RELATED PARTY TRANSACTIONS

Sponsor Shares

On September 30, 2021, our Sponsor purchased 1,725,000 shares (the “Founder Shares”) of the Company’s common stock for an aggregate price of $25,000.

Deferred Offering Costs

The Company had deferred offering costs totaling $~~579~~633,~~061~~000 and $89,606, of which $2964,~~634~~904 and $74,118 were paid by entities controlled by our founders during the ~~six~~nine months ended ~~June~~September 30, 2022 and for the period from July 19, 2021 (inception) to December 31, 2021, respectively.

Note Payable — Related Party

On September 30, 2021, the Company entered into a promissory note with its Sponsor for a principal amount of $300,000 to be used for a portion of the expenses of the Proposed Public Offering. The note is non-interest bearing, and unsecured. On August 26, 2022, the Company entered an amended and restated promissory note with its Sponsor in which the Sponsor has agreed to extend the date of this note. The amended and restated note is now payable on the earlier of: (i) August 31, 2023 or (ii) the date on which the Company consummates the Proposed Public Offering. As of September 30, 2022 and December 31, 2021, $300,000 was outstanding under the note.

~~(i) August 31, 2022 or (ii) the date on which the Company consummates~~Convertible ~~the~~Promissory ~~Proposed~~Note ~~Public~~– ~~Offering.~~Related ~~As of June 30, 2022 and December 31, 2021, $300,000 was outstanding under the note.~~Party

On August 26, 2022, the Company entered into a convertible promissory note with its Sponsor for a maximum principal amount of $1,500,000 to be used for expenses relating to the Company operating as a public entity and the search for and consummation of an initial business combination. The note is non-interest bearing, unsecured and payable on the earlier of: (i) May 12, 2023 (or up to November 12, 2023, if the period of time to consummate an initial business combination is extended) or (ii) the date on which the Company consummates an initial business combination. At any time, up to a day prior to the closing of an initial business combination, the holder may convert the principal amount into private units of the Company at a conversion price of $10.00 per unit. As of September 30, 2022, $400,000 was outstanding under the note. The convertible promissory note was valued using the fair value method. The discounted cash flow method was used to value the debt component of the convertible promissory note and the Black Scholes Option Pricing Model was used to value the debt conversion feature. The convertible promissory note is required to be recorded at its initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the note is recognized as a non-cash gain or loss on the condensed statements of operations. The fair value of the note as of September 30, 2022 was $122,439.

NOTE 4 — STOCKHOLDER’S EQUITY

Preferred Stock

The Company is authorized to issue an aggregate of 1,000,000 shares of preferred stock having a par value of $0.0001 per share. As of ~~June~~ September 30, 2022 and December 31, 2021, there were no shares of preferred stock issued or outstanding.

Common Stock

The Company is authorized to issue an aggregate of 100,000,000 shares of common stock having a par value of $0.0001 per share. From inception, July 19, 2021, through December 31, 2021, the Company issued 1,725,000 Founder Shares of common stock for $25,000. The common stock issued includes up to 225,000 shares which are subject to forfeiture by the stockholder if the underwriters of the Company’s Proposed Public Offering do not fully or in part exercise their over-allotment option.

NOTE 5 — SUBSEQUENT EVENTS

Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements~~, except for the below~~.

On August 26, 2022, the Company entered an amended and restated promissory note with its Sponsor in which the Sponsor has agreed to extend the date of the original note as discussed in Note 3 of the unaudited condensed financial statements. The amended and restated note is payable on the earlier of: (i) August 31, 2023 or (ii) the date on which the Company consummates the Proposed Public Offering.

On August 26, 2022, the Company entered a convertible promissory note with its Sponsor for a principal amount of $1,500,000 to be used for expenses relating to the Company operating as a public entity and the search for and consummation of an initial business combination. The note is non-interest bearing, unsecured and payable on the earlier of: (i) May 12, 2023 (or up to November 12, 2023, if the period of time to consummate an initial business combination is extended) or (ii) the date on which the Company consummates an initial business combination. At any time, up to a day prior to the closing of an initial business combination, the holder may convert the principal amount into private units of the Company at a conversion price of $10.00 per unit.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

References in this report (this “Quarterly Report”) to “we,” “us” or the “Company” refer to Abri SPAC 2, Inc. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to Abri Ventures 2, LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes ~~thereto~~ thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Special Note Regarding Forward-Looking Statements

This Quarterly Report includes “forward-looking statements” that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Quarterly Report including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s final prospectus for its Proposed Public Offering (as defined below within the Overview section) filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s filings with the SEC can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

Overview

We are a blank check company incorporated in the state of Delaware on July 19, 2021, for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more target businesses. Our efforts to identify a prospective target business will not be limited to any particular industry or geographic region, although we intend to focus our search on target businesses in digital media and content, electronic distribution and technology sectors. We intend to utilize cash derived from our Proposed Public Offering and the private placement of the private units, our securities, debt or a combination of cash, securities and debt, in effecting our initial business combination.

The issuance of additional shares of common stock or preferred stock in our initial business combination:

●

may significantly dilute the equity interest of our investors in our Proposed Public Offering who would not have pre-emption rights in respect of any such issuance;

●

may subordinate the rights of holders of shares of common stock if we issue shares of preferred stock with rights senior to those afforded to our shares of common stock;

●

will likely cause a change in control if a substantial number of our shares of common stock are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and most likely will also result in the resignation or removal of our present officers and directors; and

●

may adversely affect prevailing market prices for our securities.

Similarly, if we issue debt securities, it could result in:

●

default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations;

●

acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant;

●

our immediate payment of all principal and accrued interest, if any, if the debt security is payable on demand;

●

our inability to obtain necessary additional financing if the debt security contains covenants restricting our ability to obtain such financing while the debt security is issued and outstanding;

●

using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our shares of common stock if declared, expenses, capital expenditures, acquisitions and other general corporate purposes;

●

limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate;

●

increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and

●

limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages compared to our competitors who have less debt.

We have neither engaged in any operations nor generated any revenues to date. Our entire activity since inception has been to prepare for our proposed fundraising through an offering of our equity securities (“Proposed Public Offering”).

Results of Operations and Known Trends or Future Events

We have neither engaged in any operations nor generated any revenues to date. All activities through ~~June~~September 30, 2022 were related to the Company’s organizational activities, and preparation for the Company’s Proposed Public Offering, and, after our Proposed Public Offering, identifying a target company for a business combination. We will not generate any operating revenues until after completion of our initial business combination.

For the three and ~~six~~nine months ended ~~June~~September 30, 2022, we had a net ~~loss~~income of $73201,~~271~~226 and $~~117~~83,~~647~~579, respectively, consisting mainly of a non-cash gain for fair value of convertible promissory note – related party and legal and professional fees for our formation and Proposed ~~Public~~ Public Offering. The Company has no material deferred tax assets as of ~~June~~September 30, 2022.

Following our Proposed Public Offering, we will not generate any operating revenues until after completion of our initial business combination. We will generate non-operating income in the form of interest income on cash and cash equivalents after our Proposed Public Offering. There has been no significant change in our financial or trading position and no material adverse change has occurred since the date of our audited financial statements. After our Proposed Public Offering, we expect to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.

Liquidity and Capital Resources

As indicated in the accompanying financial statements, at ~~June~~ September 30, 2022, we had cash of $~~216~~229,380, negative cash flows from operating activities of $3042,~~063~~020 and ~~negative~~positive cash flows from financing of $~~203~~37,~~790~~331. Our working capital deficit as of ~~June~~September 30, 2022 was $~~672~~525,~~989~~702. Further, we have incurred and expect to continue to incur significant costs in pursuit of our financing and acquisition plans. Management plans to address this uncertainty through our Proposed Public Offering and sale of private units. We cannot provide assurance that our plans to raise capital or to consummate an initial business combination will be successful. These factors, among others, raise substantial doubt about our ability to continue as a going concern.

Our liquidity needs have been satisfied to date through receipt of approximately $25,000 from the sale of the founder shares and loans from related parties of $~~300~~700,000 that are more fully described below. Our deferred offering costs through ~~June~~September 30, 2022 were $~~579~~633,~~061~~000. We estimate that the net proceeds from (1) the sale of the units in our Proposed Public Offering, after deducting offering expenses of approximately $500,000 and underwriting discounts and commissions payable in cash of $1,200,000 (or $1,380,000, if the over-allotment option is exercised in full) and (2) the sale of the private units for a purchase price of $3,900,000 (or $4,260,000 if the over-allotment option is exercised in full), will be $62,200,000 (or $71,380,000 if the over-allotment option is exercised in full). Of this amount, $61,200,000 (or $70,380,000 if the over-allotment option is exercised in full), which include $2,100,000 of deferred underwriting commissions ($2,415,000 if the underwriter’s over-allotment option is exercised in full) payable upon our business combination, will be held in the trust account. The remaining $1,000,000 will not be held in the trust account.

We intend to use substantially all of the net proceeds of our Proposed Public Offering, including the funds held in the trust account, in connection with our initial business combination and to pay our expenses relating thereto, including a deferred underwriting commission payable to the underwriters in an amount equal to 3.5% of the total gross proceeds raised in the Proposed Public Offering upon consummation of our initial business combination. To the extent that our capital stock is used in whole or in part as consideration to effect our initial business combination, the remaining proceeds held in the trust account as well as any other net proceeds not expended will be used as working capital to finance the operations of the target business. Such working capital funds could be used in a variety of ways including continuing or expanding the target business’ operations, for strategic acquisitions and for marketing, research and development of existing or new products. Such funds could also be used to repay any operating expenses or finders’ fees which we had incurred prior to the completion of our initial business combination if the funds available to us outside of the trust account were insufficient to cover such expenses.

We believe that, upon consummation of our Proposed Public Offering, the $1,000,000 of net proceeds not held in the trust account, will be sufficient to allow us to operate for at least the next 12 months (or up to 18 months if extended), assuming that a business combination is not consummated during that time. Over this time period, we will be using these funds for identifying and evaluating prospective business combination candidates, performing business due diligence on prospective target businesses, traveling to and from the offices, plants or similar locations of prospective target businesses, reviewing corporate documents and material agreements of prospective target businesses, selecting the target business to consummate our initial business combination with and structuring, negotiating and consummating the business combination.

We expect our primary liquidity requirements during that period to include approximately $50,000 for legal, accounting, due diligence, travel and other expenses associated with structuring, negotiating and documenting any business combinations; $25,000 for legal and accounting fees related to regulatory reporting requirements, including Nasdaq and other regulatory fees; $25,000 for consulting, travel and miscellaneous expenses incurred during the search for a business combination target; $120,000 for the payment of the administrative fee to our sponsor (of $10,000 per month for 12 months or up to 18 months if extended); and approximately $780,000 for working capital that will be used for directors and officers liability insurance premiums, miscellaneous expenses and reserves.

These amounts are estimates and may differ materially from our actual expenses. In addition, we could use a portion of the funds not being placed in trust to pay commitment fees for financing, fees to consultants to assist us with our search for a target business or as a down payment or to fund a “no-shop” provision (a provision designed to keep target businesses from “shopping” around for transactions with other companies on terms more favorable to such target businesses) with respect to a particular proposed business combination, although we do not have any current intention to do so. If we entered into an agreement where we paid for the right to receive exclusivity from a target business, the amount that would be used as a down payment or to fund a “no-shop” provision would be determined based on the terms of the specific business combination and the amount of our available funds at the time. Our forfeiture of such funds (whether as a result of our breach or otherwise) could result in our not having sufficient funds to continue searching for, or conducting due diligence with respect to, prospective target businesses.

We do not believe we will need to raise additional funds following our Proposed Public Offering in order to meet the expenditures required for operating our business. However, if our estimates of the costs of identifying a target business, undertaking in-depth due diligence and negotiating an initial business combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our initial business combination. Moreover, we may need to obtain additional financing either to complete our initial business combination or because we become obligated to redeem a significant number of our public shares upon completion of our initial business combination, in which case we may issue additional securities or incur debt in connection with such business combination. Subject to compliance with applicable securities laws, we would only complete such financing simultaneously with the completion of our business combination. If we are unable to complete our initial business combination because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the trust account. In addition, following our initial business combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations.

Off-Balance Sheet Arrangements; Commitments and Contractual Obligations; Quarterly Results

As of ~~June~~September 30, 2022, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K and did not have any commitments or contractual obligations other than those described in the accompanying unaudited interim financial statements. No unaudited quarterly operating data is included in this prospectus as we have conducted no operations to date.

Critical Accounting Policies

The preparation of unaudited interim financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited interim financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. See Note 2 to our unaudited condensed financial statements for further information on our critical accounting policies.

Recent Accounting Pronouncements

Item 3. Quantitative and Qualitative Disclosures About Market Risk

As a smaller reporting company we are not required to make disclosures under this Item.

Item 4. Controls and Procedures

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under Securities Exchange Act of 1934, as amended (the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

Evaluation of Disclosure Controls and Procedures

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2022. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer had identified a material weakness in our internal control over financial reporting and that our disclosure controls and procedures were not effective. Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

A material weakness is defined as a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. The material weakness identified pertains to ineffective review controls over the preparation of our financial statements.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting except as described below.

We have been working to remediate the material weakness and have begun taking steps and plan to take additional measures to remediate the underlying causes of the material weakness, primarily through the documenting and formalizing of our internal review process and once complete, we will test these controls. The actions that we are taking are subject to ongoing senior management review, as well as audit committee oversight. Although we plan to complete this remediation process as quickly as possible, we cannot at this time estimate how long it will take to fully remediate the material weakness. If our remedial measures are insufficient to address the material weakness, or if significant deficiencies or material weaknesses in our internal control over financial reporting are discovered or occur in the future, it may adversely affect the results of our management evaluations and, when required, annual auditor attestation reports regarding the effectiveness of our internal control over financial reporting required by Section 404 of the Sarbanes Oxley Act. In addition, if we are unable to successfully remediate the material weakness and if we are unable to produce accurate and timely financial statements or we are required to restate our financial results, our common stock price may be adversely affected and we may be unable to maintain compliance with the NASDAQ listing requirements.

PART II – - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

None.

ITEM 1A. RISK FACTORS

Factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks described in the final prospectus for our Initial Public Offering filed with the SEC on July 6, 2022. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in our final prospectus for our Initial Public Offering filed with the SEC on July 6, 2022.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report:

Exhibit No.		Description
31.1*		Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*		Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**		Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS		~~Inline~~ XBRL Instance Document
101.SCH		Inline XBRL Taxonomy Extension Schema Document
101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.SCH		XBRL Taxonomy Extension Schema Document
101.DEF		~~Inline~~ XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		~~Inline~~ XBRL Taxonomy Extension ~~Label~~Labels Linkbase Document
101.PRE		~~Inline~~ XBRL Taxonomy Extension Presentation Linkbase Document
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

*	Filed herewith.

Furnished herewith. This certification is being furnished solely to accompany this report pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section 18 of the Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filings of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	ABRI SPAC 2, INC.
Date: October 11, 2022	By:	/s/ Jeffrey Tirman
Date: November 14, 2022	By:	/s/ Jeffrey Tirman
		Jeffrey Tirman
		Chief Executive Officer
		Chief Executive Officer (Principal Executive Officer)
		(Principal Executive Officer)

Date: October 11, 2022	By:	/s/ Christopher Hardt
Date: November 14, 2022	By:	/s/ Christopher Hardt
		Christopher Hardt
		Chief Financial Officer
		Chief Financial Officer (Principal Financial and Accounting Officer)
		(Principal Financial and Accounting Officer)

Filing Compare · Abri SPAC 2, Inc.